I don't like Bouris and his friends taking home so much cash....

First 6 Last

Share
Profile

Follow
highrola

508 Posts.

59

12/11/16

14:48

Post #: 20569631
Share

Originally posted by TenX ↑

The business is flawed....simple. The base of brokers YBR has is simply not wide enough to provide a return to share holders. The margins are rather skinny in 3rd party distribution of these banking products, and then YBR only keeps a small portion of that income as the broker takes home the majority of the revenue.

Add to that Bouris takes home $1m from memory, and you are that much further from break even. He needed to have opened more offices by now and sadly the business has run out of puff. I heard that existing offices are looking to leave as they feel the benefits of the brand do not match the cost to them and certainly falls short of the promises made.

I think Bouris expected that his name and reputation would have delivered more franchisees....but that just hasn't transpired.

I am betting 9 and Macquarie wished they didnt back this.....and neither can get out now. For Macquarie it was a small investment and they are funding the white label product so makes sense to stay in....another distribution arm for them.

Cant see this business surviving without something major happening.

10x

Expand

I don't like Bouris and his friends taking home so much cash. But switching to a franchise business model like Mortgage Choice MOC maybe what we need, which is in the pipeline at the moment.

Mortgage choice make around $20m in profits, pay a dividend and have a share price of $2.30 at the moment.

Now I'd like to see YBR with a share price of $2.30

YBR Price at posting: 16.5¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

First 6 Last

Add YBR (ASX) to my watchlist

I don't like Bouris and his friends taking home so much cash....

Top Stories

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Cyclone signs MOU with Vale for development of Iron Bear play

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Featured News